We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
-0.11%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
AUM
$357M
AUM Growth
-$43.8M
Cap. Flow
-$31.5M
Cap. Flow %
-8.82%
Top 10 Hldgs %
26.98%
Holding
360
New
86
Increased
29
Reduced
54
Closed
99

Top Sells

Rank Stock Value
1
TASK icon
TaskUs
TASK
+$8.12M
2
T icon
AT&T
T
+$6.09M
3
SONY icon
Sony
SONY
+$5.84M
4
ZIP icon
ZipRecruiter
ZIP
+$3.81M
5
EQC
Equity Commonwealth
EQC
+$3.79M

Sector Composition

Rank Sector Weight
1 Financials 24.45%
2 Healthcare 9.51%
3 Communication Services 8.7%
4 Industrials 7.33%
5 Technology 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$30M 8.41%
+70,000
New +$30.9M
BZFD icon
2
BuzzFeed
BZFD
$111M
$9.91M 2.77%
250,000
LUXA
3
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$9.63M 2.7%
982,000
IACC
4
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
$7.8M 2.18%
798,600
IGV icon
5
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
$7.18M 2.01%
+90,000
New +$7.35M
QQQ icon
6
PUT
Invesco QQQ Trust
QQQ
$466B
$7.16M 2%
20,000
-20,000
-50% -$7.37M
IWM icon
7
PUT
iShares Russell 2000 ETF
IWM
$82.2B
$6.56M 1.84%
+30,000
New +$6.65M
REGN icon
8
Regeneron Pharmaceuticals
REGN
$70.9B
$6.47M 1.81%
10,700
+6,700
+168% +$4.16M
PANA
9
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$5.86M 1.64%
600,000
MSTR icon
10
PUT
Strategy Inc
MSTR
$34.4B
$5.78M 1.62%
100,000
+50,000
+100% +$3.21M
JAMF
11
DELISTED
Jamf
JAMF
$5.58M 1.56%
145,000
+10,000
+7% +$343K
FMAC
12
DELISTED
FirstMark Horizon Acquisition Corp.
FMAC
$5.54M 1.55%
565,133
ASLE icon
13
AerSale
ASLE
$286M
$5.53M 1.55%
325,000
-71,162
-18% -$923K
VAQC
14
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$5.46M 1.53%
560,000
CRTO icon
15
Criteo
CRTO
$1.13B
$5.27M 1.48%
143,883
-9,917
-6% -$382K
SCPL
16
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$4.84M 1.35%
234,000
+185,432
+382% +$3.28M
PCYO icon
17
Pure Cycle
PCYO
$258M
$4.56M 1.28%
342,542
+78,014
+29% +$1.13M
MACU
18
DELISTED
Mallard Acquisition Corp. Common stock
MACU
$4.48M 1.25%
449,881
NVDA icon
19
PUT
NVIDIA
NVDA
$4.91T
$4.14M 1.16%
+200,000
New +$4.15M
TNL icon
20
Travel + Leisure Co
TNL
$4.57B
$4.09M 1.14%
75,000
-28,113
-27% -$1.54M
FLAC
21
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$4.02M 1.12%
410,299
TLSI icon
22
TriSalus Life Sciences
TLSI
$263M
$4M 1.12%
403,070
TSLA icon
23
PUT
Tesla
TSLA
$1.43T
$3.88M 1.09%
+15,000
New +$3.53M
QDEL icon
24
QuidelOrtho
QDEL
$1.19B
$3.78M 1.06%
26,800
+15,300
+133% +$2.06M
OUST icon
25
Ouster
OUST
$2.49B
$3.66M 1.02%
50,000

Similar funds

MYDA Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, MYDA Advisors held 360 positions worth $357M, down 11% from $401M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

MYDA Advisors withdrew a net $31.5M in Q3 2021, closing 99 positions and reducing 54 holdings. Its most notable exit was TaskUs, an estimated $8.12M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, MYDA Advisors opened a new position in Stevanato worth $3.29M.

  • MYDA Advisors's largest Q3 2021 buy was Stevanato: 130,000 shares worth $3.29M.
  • MYDA Advisors added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $4.16M increase.
  • MYDA Advisors's biggest Q3 2021 reduction was AT&T, cutting an estimated $6.09M.
  • MYDA Advisors fully exited TaskUs in Q3 2021, selling an estimated $8.12M.
  • MYDA Advisors's ten largest holdings make up 27% of its $357M portfolio in Q3 2021.
  • MYDA Advisors opened 86 new positions and closed 99 in Q3 2021.
  • MYDA Advisors's portfolio value fell 11% quarter-over-quarter to $357M.

Based on MYDA Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.